Latest Regulatory Approvals News

Australian Vanadium Limited advances its vertically integrated vanadium strategy with key regulatory approvals, manufacturing expansions, and a new $10 million loan facility, positioning itself for major energy storage projects.

NewPeak Metals has completed acquisition of 100% ownership of the Las Opeñas exploration permits in Argentina, with drilling scheduled for early 2026. The company also advances drilling preparations at its Tansey Gold Project in Australia, supported by strong insider buying.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.

Race Oncology has filed pivotal patents on the active (E,E)-bisantrene isomer, potentially extending its drug exclusivity by two decades, while advancing its Phase 1 clinical trial and maintaining a strong cash position.

Taiton Resources has completed key soil sampling programs targeting gold and rare earth elements at its South Australian projects, alongside heritage surveys and regulatory steps, supported by a recent $2 million capital raise.

Sarytogan Graphite Limited reports strong progress in graphite and copper exploration, securing key DFS contracts and a $3.6 million placement to advance its flagship projects.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

AGL Energy has agreed to purchase four new gas turbines for $185 million to develop the Kwinana Swift Gas 2 project, securing 176MW of reserve capacity to support Western Australia’s energy transition.

Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW, secures $34 million through capital raising, and acquires promising US exploration assets, setting the stage for growth.